Metabolic Syndrome and Rheumatoid Arthritis Activity: An Analysis of Clinical, Laboratory, and Ultrasound Parameters
- PMID: 38004150
- PMCID: PMC10674889
- DOI: 10.3390/nu15224756
Metabolic Syndrome and Rheumatoid Arthritis Activity: An Analysis of Clinical, Laboratory, and Ultrasound Parameters
Abstract
(1) Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease associated with an increased incidence of metabolic syndrome (MetS). The aim of this study was to determine if there is an association between MetS and parameters of RA activity, as well as between metabolic parameters and indices of RA activity. (2) Methods: This study involved 65 patients with RA. MetS was diagnosed according to the 2009 IDF/AHA/NHLBI criteria. The comparative analysis was conducted between RA patients with MetS (RA (MetS (+)) and without MetS (RA (MetS (-)). The activity of RA was assessed using clinical, laboratory, and ultrasound (US) parameters. (3) Results: Compared with RA MetS (-) patients, RA MetS (+) patients were characterized by higher disease activity, according to Disease Activity Score (DAS28), Simplified Disease Activity Index (SDAI), and Clinical Disease Activity Index (CDAI). RA MetS (+) patients had significantly higher tender and swollen joint counts, and values of erythrocyte sedimentation rate, C-reactive protein, and US parameters (grey-scale (GSUS), power Doppler (PDUS)). Significant correlations were found between metabolic parameters (waist circumference, cholesterol and glucose concentrations) and indices of RA activity. (4) Conclusion: The results of this study show that, in patients with RA, the presence of MetS is associated with higher disease activity, based on several clinical, laboratory, and US parameters.
Keywords: metabolic syndrome; rheumatoid arthritis; ultrasound examination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Gray Scale and Power Doppler Ultrasonographic Findings in the Assessment of Disease Activity and Their Correlation with Disease Activity Parameters in Rheumatoid Arthritis.Curr Rheumatol Rev. 2018;14(2):153-162. doi: 10.2174/1573397113666170120094136. Curr Rheumatol Rev. 2018. PMID: 28117013
-
Prevalence of metabolic syndrome in rheumatoid arthritis patients from Northeastern Brazil: Association with disease activity.Mod Rheumatol. 2018 Mar;28(2):258-263. doi: 10.1080/14397595.2017.1316813. Epub 2017 May 9. Mod Rheumatol. 2018. PMID: 28486047
-
Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study.PLoS One. 2015 Mar 4;10(3):e0118620. doi: 10.1371/journal.pone.0118620. eCollection 2015. PLoS One. 2015. PMID: 25738587 Free PMC article.
-
Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis.Int J Rheum Dis. 2021 Sep;24(9):1112-1120. doi: 10.1111/1756-185X.14147. Epub 2021 Jun 2. Int J Rheum Dis. 2021. PMID: 34076348
-
Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis.PLoS One. 2017 Mar 23;12(3):e0170361. doi: 10.1371/journal.pone.0170361. eCollection 2017. PLoS One. 2017. PMID: 28333949 Free PMC article.
Cited by
-
Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients.BMC Endocr Disord. 2024 Aug 5;24(1):140. doi: 10.1186/s12902-024-01675-5. BMC Endocr Disord. 2024. PMID: 39103813 Free PMC article.
-
Beneficial Effects of Omega-3 Fatty Acids on Obesity and Related Metabolic and Chronic Inflammatory Diseases.Nutrients. 2025 Apr 3;17(7):1253. doi: 10.3390/nu17071253. Nutrients. 2025. PMID: 40219010 Free PMC article. Review.
-
Identification of diagnostic genes and drug prediction in metabolic syndrome-associated rheumatoid arthritis by integrated bioinformatics analysis, machine learning, and molecular docking.Front Immunol. 2024 Jul 29;15:1431452. doi: 10.3389/fimmu.2024.1431452. eCollection 2024. Front Immunol. 2024. PMID: 39139563 Free PMC article.
-
Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis.Arthritis Rheumatol. 2025 Mar;77(3):263-271. doi: 10.1002/art.43034. Epub 2024 Dec 4. Arthritis Rheumatol. 2025. PMID: 39420627 Free PMC article.
References
-
- Aletaha D., Neogi T., Silman A., Funovits J., Felson D.T., Bingham C.O., 3rd, Birnbaum N.S., Burmester G.R., Bykerk V.P., Cohen M.D., et al. Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–2581. doi: 10.1002/art.27584. - DOI - PubMed
-
- Behl T., Kaur I., Sehgal A., Zengin G., Brisc C., Brisc M.C., Munteanu M.A., Nistor-Cseppento D.C., Bungau S. The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients. Int. J. Mol. Sci. 2020;21:9505. doi: 10.3390/ijms21249505. - DOI - PMC - PubMed
-
- Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C., Jr., et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials